TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
MCRB

Seres Therapeutics Inc

Healthcare · Biotechnology

2.90$ +0.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Seres Therapeutics Inc (MCRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 102 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MCRB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
368 359 341 322 179 140 164 144 143 138 118 102
214 175 165 149 73 39 66 49 52 49 32 42
170 128 111 71 67 31 59 45 48 46 30 16
170 128 111 71 67 31 59 45 48 46 30 16
17 8.7 7.4 19 – 4.8 4.4 0.9 0.8 0.4 0.2 25
19 30 42 53 – – – – – – – –
383 403 401 409 155 126 114 111 100 94 91 67
79 99 98 108 65 41 31 31 22 19 19 20
6.3 5.6 8.8 9.2 8.3 8.7 9.0 9.5 9.9 10 11 12
9.0 3.6 5.2 4.8 8.3 4.1 2.2 2.2 1.7 1.7 2.3 1.2
101 102 102 102 – – – – – – – –
-15 -45 -60 -87 24 14 50 33 44 44 26 35
-937 -978 -1,018 -1,051 -962 -978 -945 -965 -957 -972 -992 -988
6.4 6.5 7.3 7.6 7.6 8.7 8.7 8.7 8.8 8.9 9.6 9.6

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?